Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
Open Access
- 12 December 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (12) , 897
Abstract
Helicobacter pylori colonizes the human stomach of half of the world’s population. The infection if not treated, persists through life, leading to chronic gastric inflammation, that may progress to severe diseases as peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. The first line of treatment, based on 7 to 21 days of two antibiotics associated with a proton pump inhibitor, is, however, already failing most due to patient non-compliance that leads to antibiotic resistance. It is, therefore, urgent to screen for new and more efficient antimicrobials against this bacterium. In this work, Fourier Transform Infrared (FTIR) spectroscopy was evaluated to screen new drugs against H. pylori, in rapid (between 1 to 6 h), and high-throughput mode and based on a microliter volume processes in relation to the agar dilution method. The reference H. pylori strains 26,695 and J99, were evaluated against a peptide-based antimicrobial and the clinical antibiotic clarithromycin, respectively. After optimization of the assay conditions, as the composition of the incubation mixture, the time of incubation, and spectral pre-processing, it was possible to reproducibly observe the effect of the drug on the bacterial molecular fingerprint as pointed by the spectra principal component analysis. The spectra, obtained from both reference strains, after its incubation with drugs concentrations lower than the MIC, presented peak ratios statistically different (p < 0.05) in relation to the bacteria incubated with drugs concentrations equal or higher to the MIC. It was possible to develop a partial least square regression model, enabling to predict from spectra of both bacteria strains, the drug concentration on the assay, with a high correlation coefficient between predicted and experimental data (0.91) and root square error of 40% of the minimum inhibitory concentration. All this points to the high potential of the technique for drug screening against this fastidious growth bacterium.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (grant number PTDC/BIO/69242/2006)
- Agência Nacional de Inovação (CLARO)
This publication has 25 references indexed in Scilit:
- Identification of microorganisms by FTIR spectroscopy: perspectives and limitations of the methodApplied Microbiology and Biotechnology, 2013
- Identification of carbapenem‐resistant Acinetobacter baumannii clones using infrared spectroscopyJournal of Biophotonics, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: A Meta-AnalysisDigestion, 2011
- Species and strain identification of lactic acid bacteria using FTIR spectroscopy and artificial neural networksJournal of Biophotonics, 2010
- Review of the most common pre-processing techniques for near-infrared spectraTrAC Trends in Analytical Chemistry, 2009
- Global responses ofEscherichia colito adverse conditions determined by microarrays and FT-IR spectroscopyCanadian Journal of Microbiology, 2009
- Epidemiological typing of methicillin-resistant Staphylococcus aureus strains by Fourier transform infrared spectroscopyJournal of Microbiological Methods, 2007
- Mean squared error of prediction (MSEP) estimates for principal component regression (PCR) and partial least squares regression (PLSR)Journal of Chemometrics, 2004
- Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilutionClinical Microbiology and Infection, 2000